Mar 07, 2023 / 02:10PM GMT
Max Masucci - TD Cowen, Research Division - MD & Senior Research Analyst
Welcome to TD Cowen's second day of our Annual Healthcare Conference. I'm Max Masucci, one of a Cowen's Life Sciences and Diagnostic Tools Analyst. I've had the pleasure of covering Hologic since 2017 with a short stint between. But it's great to see you, thanks for being here.
Karleen M. Oberton - Hologic, Inc. - CFO
Thanks for having us.
Max Masucci - TD Cowen, Research Division - MD & Senior Research Analyst
All right. So we've got CFO, Karleen Oberton; and VP of IR, Ryan Simon.
Ryan M. Simon - Hologic, Inc. - VP of IR
Yes. Yes.
Questions and Answers:
Max Masucci - TD Cowen, Research Division - MD & Senior Research AnalystAll right. Great. Wanted to make sure I have the titles right. So let's just jump into questions. So if we compare the pre-pandemic Hologic to today, it's very different. In fiscal '19, the company generated adjusted